Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study

Clinical trial NCT04600921 · TERMINATED

Trial details

NCT number: NCT04600921
Sponsor: Medical University of Graz
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction Heart Failure With Mid Range Ejection Fraction Implantable Cardioverter-Defibrillators Cardiac Resynchronization Therapy

Start date: 2021-06-24
Primary completion: 2023-06-23
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.